[Answered] How they decide to distribute outcomes? What will be an ideal ...

This topic contains a solution. Click here to go to the answer

Author Question: How they decide to distribute outcomes? What will be an ideal ... (Read 8 times)

kamilo84

Sr. Member
Posts: 495

on: Jul 7, 2018

How they decide to distribute outcomes?

What will be an ideal response?

Question 2

The use of specific and difficult goals, if not properly monitored, could reduce ________.

A) performance
B) intrinsic motivation
C) extrinsic motivation
D) organizational citizenship behavior

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

Tonyam972

Sr. Member
Posts: 342

Reply #1 on: Jul 7, 2018

Answer to Question 1

Answer to Question 2

D

kamilo84

Member
Posts: 495

Reply 2 on: Jul 7, 2018

Wow, this really help

fatboyy09

Member
Posts: 358

Reply 3 on: Yesterday

Gracias!

« previous next »

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

The U.S. Pharmacopeia Medication Errors Reporting Program states that approximately 50% of all medication errors involve insulin.

Did you know?

The immune system needs 9.5 hours of sleep in total darkness to recharge completely.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.